IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese

Tissue Antigens

Volumn 63, Issue 3, 2004, Pages 223-230

  Yamashita, T ^a   Hamaguchi, K ^a   Kusuda, Y ^a   Kimura, A ^b   Sakata, T ^a   Yoshimatsu, H ^a  

^a OITA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Haplotype; Human leukocyte antigen; l B like gene; Promoter; Type 1 diabetes

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RESISTANCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INHIBITOR OF KAPPA B LIKE GENE; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; INFANT; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 1542359017     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00164.x     Document Type: Article

References (28)

1. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994: 371: 130-6.
2. Mein CA, Esposito L, Dunn MG et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998: 19: 297-300.
3. The MHC sequencing consortium. MHC complete sequence and gene map of a human major histocompatibility complex. Nature 1999: 401: 921-3.
4. Sheehy MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Invest 1989: 83: 830-5.
5. Hamaguchi K, Kimura A, Dong RP et al. Specific combinations of HLA-DRB and -DQB alleles confer susceptibility while the DQB gene determines resistance to insulin-dependent diabetes mellitus in Japanese. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol. 2. Oxford Oxford University Press, 1992: 488-92.
6. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-7.
7. Kobayashi T, Tamemoto K, Nakanishi K et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993: 16: 780-8.
8. Fennessy M, Metcalfe K, Hitman GA et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood diabetes in Finland (DiMe) Study Group. Diabetologia 1994: 37: 937-44.
9. Hanifi Moghaddam P, de Knijf P, Roep BO et al. Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. Diabetes 1998: 47: 263-9.
10. Lie BA, Todd JA, Pociot F et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999: 64: 793-800.
11. Albertella MR, Campbell RD. Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Hum Mol Genet 1994: 3: 793-9.
12. Semple JI, Brown SE, Sanderson CM, Campbell RD. A distinct bipartite motif is required for the localization of inhibitory kappaB-like (IkappaBL) protein to nuclear speckles. Biochem J 2002: 361: 489-96.
13. Arenzana-Seisdedos F, Turpin P, Rodriguez M et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997: 110: 369-78.
14. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997: 336: 1066-71.
15. Heimberg H, Heremans Y, Jobin C et al. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 2001: 50: 2219-24.
16. Price P, Cheong KY, Boodhoo A et al. Can MHC class II genes mediate resistance to type 1 diabetes? Immunol Cell Biol 2001: 79: 602-6.
17. de la Concha EG, Fernandes-Arquero M, Lopez-Nava G, Martin E, Allcock RJN, Conejero L et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000: 119: 1491-5.
18. Okamoto K, Makino S, Yoshikawa Y et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003: 72: 303-12.
19. Miterski B, Bohringer S, Klein W et al. Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 2002: 3: 211-9.
20. Allcock RJN, Baluchova K, Cheong KYM, Price P. Haplotypic single nucleotide polymorphisms in the central MHC gene IKBL, a potential regulator of NF-kappaB function. Immunogenetics 2001: 52: 289-93.
21. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
22. Ozaki K, Ohnishi Y, Iida A et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002: 32: 650-4.
23. Hashimoto M, Nakamura N, Obayashi H et al. Genetic contribution of the BAT2 gene microsatellite polymorphism to the age-at-onset of insulin-dependent diabetes mellitus. Hum Genet 1999: 105: 197-9.
24. Obayashi H, Hasegawa G, Fukui M et al. Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies. J Clin Endocrinol Metab 2000: 85: 3348-51.
25. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 1999: 4: 771-81.
26. Morris JF, Hromas R, Rauscher FJ III. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Mol Cell Biol 1994: 14: 1786-95.
27. Robertson KA, Hill DP, Kelley MR et al. The myeloid zinc finger gene (MZF-1) delays retinoic acid-induced apoptosis and differentiation in myeloid leukemia cells. Leukemia 1998: 12: 690-8.
28. Sekido R, Murai K, Funahashi J et al. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol Cell Biol 1994: 14: 5692-700.